Evidence map›Paper›PMID 35248146›Full record

ArticleParasites & vectors2022

The impact of COVID-19 continuous containment and mitigation strategy on the epidemic of vector-borne diseases in China.

Xiangyu Guo, Chenjin Ma, Lan Wang, Na Zhao, Shelan Liu, Wangli Xu

Abstract read
In one paragraph

Article in Parasites & vectors, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Epidemiology of common infectious diseases before and during the COVID-19 pandemic in Bavaria, Germany, 2016 to 2021: an analysis of routine surveillance data.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2023
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xiangyu Guo *Center for Applied Statistics, School of Statistics, Renmin University of China, Beijing, 100872, China.
Chenjin Ma *College of Statistics and Data Science, Faculty of Science, Beijing University of Technology, Beijing, 100124, China.
Lan Wang *Department of Geriatrics, The First Affiliated Hospital-Zhejiang University School of Medicine, Hangzhou, 310003, China.
Na ZhaoSchool of Ecology and Environment, Anhui Normal University, Wuhu, 241002, Anhui Province, China.
Shelan LiuDepartment of Infectious Diseases, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, 310051, Zhejiang Province, China. liushelan@126.com.
Wangli XuCenter for Applied Statistics, School of Statistics, Renmin University of China, Beijing, 100872, China. wlxu@ruc.edu.cn.ORCID http://orcid.org/0000-0003-2053-0941

Funding

Health Commission of Zhejiang Province, China WKJ-ZJ-2106Medical and Health Research Project of Zhejiang Health Commission 2020KY525Medical and Health Research Project of Zhejiang Health Commission 2021KY629Natural Science Foundation of Zhejiang Province GF21H260012Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences 2020-PT330-003
6 · The paper itself

Abstract

backgroundThis study explored the effect of a continuous mitigation and containment strategy for coronavirus disease 2019 (COVID-19) on five vector-borne diseases (VBDs) in China from 2020 to 2021.

methodsData on VBDs from 2015 to 2021 were obtained from the National Health Commission of the People's Republic of China, and the actual trend in disease activity in 2020-2021 was compared with that in 2015-2019 using a two-ratio Z-test and two proportional tests. Similarly, the estimated trend in disease activity was compared with the actual trend in disease activity in 2020.

resultsThere were 13,456 and 3684 average yearly cases of VBDs in 2015-2019 and 2020, respectively. This represents a decrease in the average yearly incidence of total VBDs of 72.95% in 2020, from 0.9753 per 100,000 population in 2015-2019 to 0.2638 per 100,000 population in 2020 (t = 75.17, P < 0.001). The observed morbidity rates of the overall VBDs were significantly lower than the predicted rates (47.04% reduction; t = 31.72, P < 0.001). The greatest decline was found in dengue, with a 77.13% reduction (observed rate vs predicted rate: 0.0574 vs. 0.2510 per 100,000; t = 41.42, P < 0.001). Similarly, the average yearly mortality rate of total VBDs decreased by 77.60%, from 0.0064 per 100,000 population in 2015-2019 to 0.0014 per 100,000 population in 2020 (t = 6.58, P < 0.001). A decreasing trend was also seen in the monthly incidence of total VBDs in 2021 compared to 2020 by 43.14% (t = 5.48, P < 0.001).

conclusionsThe results of this study verify that the mobility and mortality rates of VBDs significantly decreased from 2015-2019 to 2020-2021, and that they are possibly associated to the continuous COVID-19 mitigation and contamination strategy implemented in China in 2020-2021.

Indexed as

COVID-19EpidemicsVector Borne DiseasesChinaHumansSARS-CoV-2COVID-19Mitigation and contamination strategyMobilityMortalityPredictionVector-borne diseases

Identifiers

PMID35248146
PMCPMC8898061

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.